K. Zakharov

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, The Lancet Regional Health - Europe.

Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial

G. Ignatyev, Y. Ulitina, L. Kozlovskaya, 2022, medRxiv.

SELECTING THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS B AFTER THE COMPLETION OF THE LONG-TERM ANTIVIRAL THERAPY

E. Esaulenko, K. A. Zakharov, A. A. Sukhoruk, 2018, Journal Infectology.

An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy Adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, SSRN Electronic Journal.

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

G. Ignatyev, L. Kozlovskaya, V. Akimkin, 2023, Viruses.

Effect of food intake on pharmacokinetic profile of the new original drug «Respoxyton» in healthy volunteers

Y. Dzhurko, A. I. Bashkatova, L. Shitov, 2023, Medical Technologies. Assessment and Choice.